Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation.
The assembly of lipoprotein(a) (Lp(a)) particles occurs via a two-step mechanism in which noncovalent interactions between apolipoprotein(a) (apo(a)) and the apolipoproteinB-100 component of low density lipoprotein precede the formation of a single disulfide bond. Although we have previously demonstrated that the rate constant for the covalent step of Lp(a) assembly can be enhanced by altering the conformational status of apo(a), the resultant rates of covalent Lp(a) particle formation measured in vitro are relatively slow. The large excess of Lp(a) (over apo(a)) observed in vivo can be accounted for by a preferential clearance of apo(a) over Lp(a) and/or a sufficiently high rate of covalent Lp(a) assembly. In the present study, we report that cultured human hepatoma cells secrete an oxidase activity that dramatically enhances the rate of covalent Lp(a) assembly. This activity is likely possessed by a protein because it is heat-sensitive and is retained in the concentrate following ultrafiltration through a 5 kDa cutoff filter. However, a small molecule cofactor for the activity is suggested by the observation that the activity is lost upon dialysis. Plots of Lp(a) assembly rate versus input apo(a) concentration gave rectangular hyperbolae; the reaction displayed an unusual dependence on the concentration of apoB-100, with increasing concentrations of apoB-100 resulting in slower rates of Lp(a) assembly at low concentrations of apo(a), an effect that was alleviated by higher apo(a) concentrations. Interestingly, V(max(app))/K(m(app)) ratios were insensitive to apoB-100 concentration, which is diagnostic of a ping-pong reaction mechanism. In this way, the putative Lp(a) oxidase may be functionally analogous to protein disulfide isomerase, which exhibits a similar mechanism during the catalysis of disulfide bond formation during protein folding, although we have ruled out a role for this enzyme in Lp(a) assembly.
Becker
Lev
L
Department of Biochemistry, Queen's University, Kingston, Ontario, Canada K7L 3N6.
Nesheim
Michael E
ME
Koschinsky
Marlys L
ML
D053299:Apolipoprotein B-100; D001054:Apolipoproteins A / Q000494:pharmacology; D001055:Apolipoproteins B / Q000494:pharmacology; D002384:Catalysis / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D004220:Disulfides / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D017270:Lipoprotein(a) / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*; D019704:Protein Disulfide-Isomerases / Q000378:metabolism; D020836:Protein Structure, Quaternary / Q000187:drug effects
D053299:Apolipoprotein B-100; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D017077:Culture Media, Conditioned; D004220:Disulfides; D017270:Lipoprotein(a); D010088:Oxidoreductases; D019704:Protein Disulfide-Isomerases